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Abstract.
Background: A number of studies evaluating physical therapy and exercise interventions in Huntington’s disease have been
conducted over the past 15 years. However, an assessment of the quality and strength of the evidence in support of these
interventions is lacking.
Objective: The purpose of this systematic review was to investigate the effectiveness of physical therapy and exercise
interventions in people with Huntington’s disease, and to examine the perceptions of patients, families and caregivers of
these interventions.
Methods: This mixed-methods systematic review utilized the Joanna Briggs Institute (JBI) approach and extraction tools to
evaluate the literature from January 2003 until May 2016. The review considered interventions that included exercise and
physical therapy interventions, and included both quantitative and qualitative outcome measures.
Results: Twenty (20) studies met the inclusion criteria, including eighteen (18) that had quantitative outcome measures and
two (2) that utilized qualitative methods. JBI Levels of evidence for the 18 quantitative studies were as follows: Eight studies
were at evidence Level 1, seven were at Level 2, two were at Level 3, and one was at Level 4.
Conclusions: Our review suggests that there is preliminary support for the benefits of exercise and physical activity in
Huntington’s disease in terms of motor function, gait speed, and balance, as well as a range of physical and social benefits
identified through patient-reported outcomes. Variability in mode of intervention as well as outcome measures limits the
interpretability of these studies, and high-quality studies that incorporate adaptive trial designs for this rare disease are
needed.
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INTRODUCTION
Physical therapy and exercise are promising inter-
ventions for those with neurodegenerative diseases
including Huntington’s disease (HD) [1, 2]. Over the
last 15–20 years, there has been a significant increase
in the number of research studies devoted to eval-
uating both the feasibility and efficacy of physical
therapy and exercise interventions in individuals with
neurodegenerative diseases highlighting the potential
to not only improve daily activity performance, func-
tion, cognition and quality of life, [3–6] but also to
slow disease progression [7, 8].
Current available pharmacologic treatments for
HD are aimed at decreasing involuntary choreic
movements, however no interventions to date have
demonstrated an ability to alter the progression of the
disease or effectively manage motor symptoms. Exer-
cise interventions aimed at improving the range of
motor and cognitive impairments in people with HD
may provide a long-term beneficial effect to maxi-
mize functional abilities, maintain independence over
a longer period and potentially impact the progression
of the disease. Indeed, loss of independent mobility
and care dependency have been shown to be impor-
tant predictors of nursing home admissions in people
with HD and those with dementia [9, 10].
In 2003, a systematic review on the effectiveness
of physiotherapy, occupational therapy and speech
therapy in HD was published; [11] however, at the
time there was little in the published literature that
could support the use of physical therapy for address-
ing disease-specific impairments in HD. In the past
10 years, there has been a significant increase in the
number and quality of physical therapy and exercise
studies in HD [12–18]. These studies have ranged
from the evaluation of short-term exercise programs,
[13, 14, 18] video-game home interventions, [15] as
well as inpatient multidisciplinary rehabilitation pro-
grams [12, 16, 17]. However, despite the increase in
published studies and trials, a search of the Joanna
Briggs Institute (JBI) and Cochrane Library high-
lighted no further published systematic reviews of
physiotherapy and Huntington’s disease. One pro-
tocol evaluating non-pharmacologic health-related
behaviors in HD was identified in Prospero [19], but
to date no results have been published.
In 2009, a Physiotherapy Guidance Document was
developed by the European Huntington’s Disease
Network (EHDN) [20] based on a structured search
of the available literature and expert consensus
at the time. The aim of the Guidance Document
was to provide, where possible, a scientific evidence-
based document to inform the optimal, individualized
physical therapy management of people with
HD. Treatment-based classifications were further
developed in 2012, aimed at guiding clinical decision-
making across the life course of the disease [21].
While the EHDN Guidance Document and sub-
sequent treatment-based classifications were an
important first step for providing information about
patient management in this relatively rare disease,
we are now at a point where more rigorous clinical
guidelines need to be developed. Importantly, such
guidelines should be informed by a complete and
systematic review of the existing literature.
This mixed-methods systematic review utilized the
JBI approach and extraction tools to evaluate the
available literature. By combining quantitative and
qualitative syntheses in the same review, we set out to
answer the following questions: 1) what is the effec-
tiveness of physical therapy and therapeutic exercise
interventions in people with HD? and 2) what are
patients, families and caregivers’ perceptions of these
interventions?
MATERIALS AND METHODS
The protocol for this systematic review was devel-
oped in accordance with guidelines from JBI (http://
joannabriggs.org/assets/docs/sumari/Reviewers-
Manual-2014.pdf; accessed 06/07/2017), and has
been previously published [22]. We considered both
experimental and epidemiological study designs
including randomized controlled trials (RCTs), non-
randomized controlled trials, quasi-experimental
studies, before and after studies, prospective and
retrospective cohort studies, case control studies and
analytical cross-sectional studies. The qualitative
component of the review considered studies that
focused on qualitative data including designs such
as phenomenology, grounded theory, ethnography,
action research and feminist research.
Search strategy
A three-step search strategy was utilized for each
component in this review. An initial limited search
of PubMed and CINAHL was undertaken followed
by an analysis of the text words contained in the
titles and abstracts, and of the article index terms.
A second, comprehensive search using all identified
keywords and index terms was undertaken across
seven databases and grey literature sources. Third,
N.E. Fritz et al. / Physical Therapy and Exercise in Huntington’s Disease Systematic Review 219
the references from all selected reports and arti-
cles were manually searched for additional studies.
Studies published in English between January 2003
and May 2016 were considered for inclusion in this
review. This date was chosen as our start date for our
search as this was the completion date for the previous
systematic review [11].
The databases searched were: CINAHL, PEDro,
MEDLINE via PubMed, Cochrane Library, Scopus,
SPORTDiscus, and PsycINFO. In addition to the
relevant references from selected articles, sources
of additional grey literature included: Google, Web
of Science (Books, proceedings, other), ClinicalTri-
als.gov, WHO International Clinical Trials Registry
Platform (ICTRP), ISRCTN Registry, Prospero,
National Guideline Clearinghouse (NGC), resources
from professional organizations such as: Hunting-
ton Study Group (HSG), EHDN, and the American
Physical Therapy Association (APTA). Primary key-
words used in the searches were: huntington* disease,
physical therap*, physical activit*, exercise, and
physiotherapy*. Additional text words included the
specific forms of exercise and mobility intervention
(see Interventions section below).
Interventions
This review considered studies that evaluated
physical therapy and exercise interventions such as
aerobic exercise, strengthening exercises, gait or
walking training, treadmill training, balance train-
ing, yoga, Pilates, Tai-chi (and variants), relaxation,
technology-delivered exercise, dance, aquatics, daily
living strategies, sensory stimulation, cueing (i.e.,
visual, verbal or physical prompts including atten-
tional strategies with internal cues), chaining (i.e.,
breaking down the task), dual-task training (i.e.,
motor-cognitive training), task-specific training, edu-
cation, flexibility range of motion (ROM) exercises,
breathing exercises, wheelchair evaluation, seating,
wheelchair mobility training, positioning, splinting,
posture (alignment and exercises), manually assisted
cough, and non-invasive ventilation.
Outcome measures
The quantitative component of this review con-
sidered studies that included outcome measures
for physical and cognitive function. Outcome mea-
sures of physical function included: balance, fitness
(cardiovascular function), goal attainment, motor
function and performance, muscle strength, num-
ber of falls, physical activity, pulmonary function,
rate of chest infections, ulcer staging, spatiotempo-
ral and kinematic parameters of gait and balance,
walking ability and endurance. Outcome mea-
sures of cognitive function included cognition and
psychological measures (depression, anxiety, and
apathy).
The qualitative components of this review consid-
ered studies that identified patient, family or caregiver
perceptions of physical therapy and exercise inter-
ventions including patient and family/caregiver
experiences, perceived improvement and satisfaction
where these have been explored using qualitative
methods.
Context
This review considered studies that investigated
physical therapy and exercise interventions that were
carried out in the community, hospital settings, clin-
ics, rehabilitation centers, or patient’s homes.
Data extraction and assessment
of methodological quality
Data were extracted from papers included in the
review using standardized data extraction tools from
the JBI (JBI Meta-Analysis of Statistics Assessment
and Review Instrument: JBI-MAStARI; JBI Qualita-
tive Assessment and Review Instrument: JBI-QARI;
JBI Institute Narrative, Opinion and Text Assess-
ment and Review Instrument: JBI-NOTARI). The
data extracted included specific details about the
population, setting, context, methods and outcome,
related to the review questions and specific objec-
tives. Papers selected for retrieval were assessed
by two independent reviewers for methodological
validity prior to inclusion in the review. Follow-
ing completion of the appraisal instruments, all
articles were verbally discussed in a group set-
ting, and any disagreements were resolved through
discussion.
Data synthesis
As the experimental studies included in this review
used a range of different types of interventions to
address a variety of outcomes, it was not possible
to pool the results using the statistical meta-analysis
process embedded in JBI-MAStARI. Quantitative
findings from the experimental and descriptive obser-
vational studies are therefore presented in a narrative
form. As only two qualitative studies were included
in the final review, meta-synthesis was not under-
taken and the results are presented in narrative form.
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Fig. 1. PRISMA Flowchart for identifying studies for systematic review.
Narrative, opinion and textual documents are not
included in this review.
RESULTS
As shown in the PRISMA flowchart (Fig. 1), a sys-
tematic literature search across all sources returned
2,315 items, including 62 found in references and
other grey literature sources. Following the removal
of 201 duplicates, 2,114 unique records remained.
The title and abstracts of these records were reviewed
with 2,083 resources excluded due to not meet-
ing inclusion criteria (the majority were drug or
non-investigative studies). Finally, the full-text of
31 papers was scrutinized further with 11 papers
assessed as not meeting inclusion criteria. A con-
sensus between all authors was reached to identify
the final 20 papers included in this review; two
papers were included based on qualitative synthe-
sis, 18 were included based on quantitative synthesis.
All 20 studies met the criteria, which included that
they were published in 2002 or later, were written
in English, and were intervention studies of physical
therapy, physical activity or exercise. Combined, the
20 papers assess physical therapy interventions and
outcomes for 441 study participants. The majority of
the studies, 14, were conducted in Europe (U.K., Italy,
Norway, Germany, and Poland) while Australia and
the United States were each home to three studies.
Seventeen of the 20 papers were published between
2013 and 2016.
Quantitative studies
The 18 quantitative studies are summarized in
Table 1. Results are summarized below according to
outcomes related to the International Classification of
Functioning, Disability and Health (body structure
and function, activity limitations and participation
restrictions). JBI levels of evidence for the studies
were as follows: Eight studies were at evidence Level
1, seven were at Level 2, two were at Level 3, and one
was at Level 4.
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Table 1
Summary of eighteen quantitative studies included in systematic review of exercise and physical therapy interventions in people with Huntington’s disease (HD)
Study author
& year
JBI Level of
Evidence
Inclusion criteria &
number of
participants
Intervention of interest Outcomes Number of
treatments
Session
duration
Program
duration
Results
Bohlen et al.
[24]
2.d-Pre-test –
post-test
control group
study
12 adults with
manifest
Huntington’s
disease; mean age
50.0± 17 years
(42% men).
Physical therapy at outpatient
clinic focused on transfer
and gait training, balance
and posture exercises and
motor coordination tasks.
UHDRS-TMS,
Spatiotemporal gait
measures (GAITRite),
TUG, BBS, and Force
Plate
2 times per
week
60 minutes 6 weeks Excellent compliance with
attendance of 90% PT sessions.
Significant changes in %
double support, stride length,
gait velocity, BBS, and TUG.
No significant changes for
stride length and gait velocity
in the fast speed condition.
Force Plate UHDRS-TMS
measures showed no significant
differences after therapy.
Busse et al.
[14]
1.c- randomized
controlled
trial
31 adults with
confirmed HD and
able to walk
independently;
early to middle
stages; 16 in
intervention group,
15 in control group;
mean age
53.3± 12.5 (50%
men).
Supervised gym sessions of
stationary cycling and
resistance exercises and
unsupervised home-based
walking program consisting
of 1) aerobic training at
55%–75% age-predicted
maximal HR & moderate to
hard levels of exertion on
Borg RPE (4–6); 2)
strength training for
trunk/LE muscles
progressed to 2 sets of 8–12
reps at 60–70% of
participant’s 1 repetition
max and 3) walking at
moderate to somewhat hard
(3-4 Borg scale) intensities;
control group did usual
care.
Feasibility
(retention/adherence
rates), acceptability,
safety; UHDRS mMS;
10MWT, 30-s chair
stand test, Romberg
test, submaximal
exercise test
(HR/perceived exertion
at minute 9); daily step
counts, % of sedentary
time, % time in
moderate/high physical
activity (activity
monitors); self-reported
7-day physical activity
recall; 6MWT; SF-36;
UHDRS cognitive
scales.
1 time per
week (gym);
2 times per
week
(home)
30 minutes
(gym and
home)
12 weeks Intervention was feasible, safe,
and acceptable. Seven
individuals achieved 150
minutes of moderate physical
activity for each week of the
intervention. Intervention
group had a significant
improvement in SF-36 Mental
Component Summary score
(ES = 0.53) and non-significant
improvements in UHDRS
cognitive scores (0.40), 6MWT
(0.44); 30 s chair stand test
(0.25), and HR at minute 9 of
exercise test (-0.25).
(Continued)
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Table 1
(Continued)
Study author
& year
JBI Level of
Evidence
Inclusion criteria &
number of
participants
Intervention of interest Outcomes Number of
treatments
Session
duration
Program
duration
Results
Ciancarelli
et al. [32]
2.d- Pre-test –
post-test
control group
study
34 adults with
genetically
confirmed HD who
could understand
tests and exercise
sequences and were
able to
self-ambulate; early
to middle stages;
mean age 42± 7.0
(35% men).
Intensive inpatient
multidisciplinary
neurorehabilitation
program consisting of
conventional neuromotor
rehabilitation (balance,
coordination, gait, posture,
and strengthening
exercises), light aerobics
(cycling/walking), and OT
for hand dexterity and fine
motor function exercises.
Barthel Index, Tinetti
Scale, Physical
Performance Test, total
Functional Capacity
Scale
2 times per
day (neuro-
motor rehab
and OT); 1
time per day
(aerobics)
2 hours per
day (neuro-
motor rehab
and OT); 20
minutes per
day
(aerobics)
3 weeks Significant (p< 0.001)
improvements in all outcome
measures in all participants
after completion of
neurorehabilitation program.
Clark et al.
[28]
4.c- Case series 2 adults with manifest
HD and 1 at risk for
Huntington’s
disease (1 man and
2 women; mean age
28.0± 1.5 years).
Outpatient program with 4
key features: 1)
com-munity-based group
format for individuals with
HD, caregivers, and those
at-risk for HD; 2)
individualized prescription
within the group design; 3)
circuit training; and 4) use
of outcome measures.
10MWT, BBS, Fatigue
Impact Scale, and TUG.
Once a week 60 minutes 8 weeks All 3 individuals improved on the
TUG, 10MWT. One individual
also improved on the BBS and
the Fatigue Impact Scale. This
individual had the highest
disease burden.
Cruickshank
et al. [31]
2.d- Pre-test –
post-test
control group
study
15 adults with
manifest
Huntington’s
disease; mean age
52.5± 6.6 (53%
men).
Multidisciplinary
rehabilitation program of
aerobic and resistance
exercises in clinic,
home-based exercise
program, and OT focused
on cognitive rehabilitation.
Structural Magnetic
Resonance Imaging of
gray matter volume;
Hopkins verbal learning
test; Trail Making test;
Color Word
interference test;
SDMT.
1 time per
week
(clinic), 3
times per
week
(home),
every other
week (OT)
60 minutes 9 months Significant increases in GM
volume in right caudate and
bilaterally in the DLPFC after
multidisciplinary rehab.
Volumetric increases in GM
were accompanied by
significant improvements in
Hopkins Verbal Learning-Test.
GM volume increases in the
DLPFC correlated with
performance on verbal learning
and memory.
N.E.F
ritz
et
al./PhysicalTherapy
a
nd
Exercise
in
H
untington’sD
isease
System
atic
Review
223
Dawes et al.
[29]
3.e- Observa-
tional study
without a
control group
13 adults with
confirmed HD in
early and middle
stages (9 analyzed);
20 age and
gender-matched
healthy controls;
mean age 51.0± 11
years (55% men).
Supervised gym sessions of
stationary cycling and
resistance exercises and
unsupervised home-based
walking program consisting
of 1) aerobic training at
55%–75% age-predicted
maximal HR & moderate to
hard levels of exertion on
Borg RPE (4–6); 2)
strength training for
trunk/LE muscles
progressed to 2 sets of 8–12
reps at 60–70% of
participant’s 1 repetition
max and 3) walking at
moderate to somewhat hard
(3-4 Borg scale) intensities;
control group did usual
care.
Blood pressure; work rate
(watts) phase a
(unloaded cycling for 3
mins); HR (beats per
minute) phase a minute
3; Borg RPE phase a
minute 3; work rate
(watts) phase b
(65–75% heart rate
reserve); HR (beats per
minute) phase b minute
9; Borg RPE phase b
minute 9.
1 time per
week (gym);
2 times per
week
(home)
aerobic
training 30
minutes
followed by
strength-
ening
exercises;
home-based
walking
program 30
minutes per
day
12 weeks 4 participants did not complete
the intervention; no observable
group training effects were
found on any of the outcome
measures in the 9 participants
that completed the intervention;
however, there was a wide
variability in responses with
some individuals showing a
large training response and
others none.
Jones et al.
[30]
1.d-Pseudo-
randomized
controlled
trial
20 adults with
confirmed HD and
stable meds;
premanifest and
manifest stages; 10
in intervention
group; 10 in
placebo group.
Home-based resistive
inspiratory muscle training
at 50% of maximal
inspiratory pressure (MIP)
using the
POWERbreathe®K3
device; resistance was
10 cmH2O for placebo
group.
SNIP; cough efficacy
measured with PCF;
Adherence (number of
training sessions
completed).
2 sessions per
day
30 breaths 6 weeks Nonsignificant increases in SNIP
and PCF for both groups;
pooled data showed small
effect sizes for SNIP (ES 0.36)
and PCF (0.37); adherences
were 70.67± 26.35% for the
intervention group and
74.53± 21.03% for placebo
group.
Khalil et al.
[13]
1.c- randomized
controlled
trial
25 individuals
mild/moderate HD;
13 exercise group;
12 in control group.
Mean age
52.5± 13.5 years.
Supervised home exercise
program using a DVD and
a walking program. One
home visit to teach the
program and then weekly
follow up phone calls.
UHDRS-mMS; Gait
analysis measures using
GaitRite including gait
speed and
spatiotemporal
measures of gait,
SF-36.
3 times a week
(DVD
exercises); 1
time a week
(walking)
45 min DVD;
30 minutes
walking
8 weeks Intervention safe and feasible;
Experimental group had
significant improvements in
gait (velocity ES 1.7), &
UHDRS-mMS (ES 1.1). No
significant changes in step
time, step time CV, and the
SF-36. Balance improved
(BBS ES 1.4); not blind rated.
(Continued)
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(Continued)
Study author & year JBI Level of
Evidence
Inclusion criteria &
number of
participants
Intervention of interest Outcomes Number of
treatments
Session
duration
Program
duration
Results
Kloos et al. [43] 3.e- Observa-
tional study
without a
control group
21 adults with
confirmed diagnosis
of HD able to walk
a minimum of 10 m
without an AD or
assist and follow
instructions on
UHDRS cognitive
tests; early to
middle stages;
mean age 49.3± 11
(52% men).
Forward walking at a
comfortable pace across a
GAITRite walkway and
around two obstacles in a
figure-of-eight pattern
using no AD and with each
of 6 different ADs.
Regular forward walking:
gait spatiotemporal and
variability (coefficients
of variation) measures;
Figure-of-eight: gait
speed, observed
numbers of stumbles
and falls
Regular
forward
walking: 4
trials each
condition;
Figure-of-
eight: 2
trials each
condition
1.5 hours 1 day Across devices, walking with
the four-wheeled walker
produced a gait pattern
with the lowest double
support time and variability
in step to step measures
compared to other devices.
Figure-of-eight: faster
completion times and less
stumbles and falls using
four-wheeled walker than
all other devices except for
the three-wheeled walker.
Kloos et al. [15] 1.c- randomized
controlled
trial
24 adults with HD
able to walk 10 m
without assistance,
wide disease
severity; 13
intervention; 11
control (18
analyzed); mean
age 50.7± 14.7
years (40% men).
Playing the video game
Dance Dance Revolution
with therapist supervision
in homes; control group
played a handheld video
game unsupervised.
Feasibility (ability to play
game, adherence),
acceptability, and safety
(vitals, adverse events);
spatiotemporal gait
parameters; FSST,
Tinetti Mobility Test,
ABC scale; WHO
QOL-Bref scale
2 days per
week
45 minutes 6 weeks 6 participants couldn’t receive
intervention for medical
reasons; feasible (game
play improved, 100%
adherence), acceptible (17
out of 18 participants stated
they liked playing Dance
Dance Revolution and safe;
significant decrease in
double support percentage
in forward walking and
backward walking; no
significant changes in
FSST, ABC scale, and
WHO QOL Bref.
Mirek et al. [25] 2.d- Pre-test –
post-test
control group
study
30 individuals with
early-mid stage HD.
(TFC I-III); mean
age 43.4± 13.8
years.
PNF intervention in an
outpatient clinic focused on
balance and gait.
10 m walk, 20 m walk,
TUG, Tinetti Gait Test,
Functional Reach,
BBS, Pastor Test.
3 times a week 90 minutes 3 weeks Statistically significant
improvement in balance
and gait, as measured by
10MWT, 20 m walk test,
TUG, Tinetti Gait test,
Functional Reach, BBS and
Pastor Test.
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Piira et al. [16] 2.d- Pre-test –
post-test
control
group study
37 adults with
early-mid stage
Huntington’s
disease (TFC stages
I-III); mean age
52.4± 13.1 (49%
men).
Multi-disciplinary inpatient
rehabilitation program
focused on physical
exercise, social activities,
and group/teaching
sessions.
TUG; 10MWT; 6MWT;
BBS; ABC Scale;
Barthel Index; MMSE;
UHDRS Cognitive
Assessments; HADS;
Short Form-12; and
BMI
15 sessions
repeated 3
times a year
8 hours of
multi-
disciplinary
therapy a
day
3 weeks
repeated
3 times a
year
There were significant
improvements in gait
measures from baseline
through stay 2 and 3 to
evaluation stay with mean
changes as follows: TUG
–1.32 seconds, 10MWT
–0.27 m/s and 6MWT
+68.71 m. Balance
improved with mean BBS
change baseline to
evaluation stay of +1.0
(p< 0.03). No significant
changes in mean UHDRS
cognitive scores. Anxiety
and depression (HADS)
were significantly reduced
(3.54 points, p< 0.001).
Significant improvement in
SF-12 physical component
scores, but not in the
mental component score.
Participants gained some
weight during the project
period, with a change in
BMI of 0.72 units
(p< 0.024) from baseline to
evaluation stay. No change
was seen in ADL function
(Barthel Index).
Piira et al. [27] 2.d- Pre-test –
post-test
control
group study
10 adults with
early-mid stage
Huntington’s
disease (TFC stages
I-III): mean age
50± 14.0 (50%
men).
Multi-disciplinary inpatient
rehabilitation program
focused on physical
exercise, social activities,
and group/teaching
sessions.
TUG; 10MWT; 6MWT;
BBS; ABC Scale;
Barthel Index; MMSE;
UHDRS Cognitive
Assessments; HADS;
Short Form-12; and
BMI.
15 sessions
repeated 3
times a year
8 hours of
multi-dis-
ciplinary
therapy a
day
3 weeks at
3 times a
year
After 24 months individuals
who participated in the
program 3 times per year
showed small,
non-significant declines in
gait, balance, and cognition
(except MMSE). Anxiety
and depression (HADS)
improved, while BMI and
quality of life (Short
Form-12) did not change.
(Continued)
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(Continued)
Study author & year JBI Level of
Evidence
Inclusion criteria &
number of
participants
Intervention of interest Outcomes Number of
treatments
Session
duration
Program
duration
Results
Quinn et al. [23] 1.c- randomized
controlled
trial
30 adults with
mid-stage HD; 15 in
intervention; 13 in
control group; mean
age 57.0± 10.1
years (46% men).
Home-based task specific
intervention program
delivered by a physical
therapist, up to a maximum
of 15 sessions. Participants
wore HR monitors during
sessions. Programs were
individualized to
participants’ specific
activity limitations in
walking, sit-to-stand
transfers, and standing
ability and modified to their
home environments.
Control group continued
usual care.
Goal Attainment Scale;
Physical Performance
Test; UHDRS-TMS;
UHDRS cognitive;
BBS; Gait Speed; Fast
Gait Speed; 30 second
Chair Rise; TUG;
Vitality Score; HADS;
HDQoL; EQ5D Health
Index;
2 times
a week
60 minutes 8 weeks The study demonstrated
feasibility of doing task
specific activities in clients
with HD who agree to
participate. Adherence was
96.9% in the experimental
group. Of note almost half
of those approached were
not interested which may
reflect low interest in
exercise or home based
therapy (as noted by the
authors). On the Goal
Attainment Scale 92% met
their goals; all other
measures had small and
non-significant effect sizes.
Quinn et al. [18] 1.c- randomized
controlled
trial
32 adults with
confirmed HD in
early to middle
stages. Adults on
stable meds, able to
speak English, able
to ride exercise
bike, and not
currently
exercising; 17 in
intervention group;
15 in control group;
mean age 53.0± 11
years (53% men).
The intervention group
participated in a 12-week
exercise program
performed in a gym or at
home. Health professionals
delivered the intervention,
and monitored exercise
dose, progression and
safety. Support by trainers
was tapered. Sessions
followed a set program:
5-min warm up and up to
25 min on the bike within
an aerobic zone, 10–15 min
of strengthening (LE and
core activities), 5 min of
stretching. Control group
continued usual care.
Feasibility (retention and
adherence rates),
acceptability, and
safety; VO2 max,
UHDRS mMS,
3-minute walk test,
finger tapping, IPAQ,
simple and complex
dual task, trailmaking A
& B, Stroop, word
fluency, SDMT, HADS,
EQ5D Health Index and
weight.
3 times
a week
50 minutes 12 weeks The intervention was safe and
feasible. Significant
improvements in VO2 max
(ES = 0.73) and
UHDRS-mMS (0.43);
significantly lower weight
in experimental group
(0.13). Non-significant
improvement in 3 minute
walk (0.08), finger tapping,
IPAQ (0.42), simple dual
task walk time (0.06),
complex dual task walk
time (0.18), SDMT (0.01),
verbal fluency (0.2), Stroop
color naming (0.31), word
reading (0.26), interference
(0.08), trailmaking A,
trailmaking B (0.02),
HADS, and EQ5D Health
Index (0.34).
N.E.F
ritz
et
al./PhysicalTherapy
a
nd
Exercise
in
H
untington’sD
isease
System
atic
Review
227
Reyes et al.
[26]
1.c- randomized
controlled
trial
18 adults with
genetically
confirmed HD with
verified disease
expression, and
ability to
understand and
respond to
instructions; 9 in
the intervention
group; 9 in control
group; mean age
was 56± 10.2 (61%
men).
Home-based resistive
inspiratory and expiratory
muscle training.
Intervention group:
progressively increased
resistance from 30% to
75% of each patient’s
maximum respiratory
pressure; Control group:
fixed resistance of
9 cmH2O.
MIP, MEP, spirometry
(slow vital capacity,
FVC, MVV, forced
expiratory FEV1, PEF
and the ratio of forced
expiratory volume in
one second to forced
vital capacity
(FEV1/FVC)), 6MWT,
dyspnea,
water-swallowing test,
SWAL Qol
questionnaire
6 days per
week
5 sets of 5
reps of
inspiratory
and
expira-tory
exercise
4 months There were greater
improvements in MIP
(ES = 2.8), MEP (1.5), FVC
(0.80), FEV1 (0.90) and
PEF (0.80) for the
intervention group
compared to the control
group after 4 months of
training; small positive
effects seen in swallowing
function, dyspnea
sensation, and six minute
walking for the intervention
group.
Thompson
et al. [17]
1.d- pseudo-
randomized
controlled
trial
20 adults with
confirmed HD,
clinical disease
diagnosis, able to
follow verbal
instruction and
perform
sub-maximal
exercise; early to
middle stages; 9 in
intervention group;
11 in the control
group (mean age
53.8± 2.9 years).
Outpatient clinic exercise
program (supervised group
sessions including 5 minute
warm-up, 10 minute
aerobic exercise, 40 minute
resistance exercise, 5
minute cool-down),
home-based exercise
program, and OT program
focused on deficits
identified by psychologists.
Primary outcome
measure:
UHDRS-TMS;
Secondary: body
composition, SOT,
ABC Scale-UK,
strength, SDMT,
Hopkins Verbal
Learning Test-R, Color
Word Interference Test,
Trail Making Trials,
Beck Depression
Inventory-II; Goal
Attainment Scale;
SF-36; and
Huntington’s-Disease-
Quality-of-Life-
Battery-for
Carers.
1 time per
week
(clinic); 3
times per
week
(home);
once every 2
weeks (OT)
1 hour (clinic,
home, and
OT)
9 months
(clinic);
6 months
(home
program
and OT)
Compared to control
participants, the
intervention group
exhibited reduced motor
(UHDRS-TMS chorea and
tandem walking) and
postural stability (Sensory
Organization Test)
deterioration, and
significantly increased fat
mass, fat-free mass, and
lower/upper body strength,
decreased written errors
(SDMT), and increased
performance on the ABC
Scale-UK walking-up-and-
down-stairs.
(Continued)
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(Continued)
Study author & year JBI Level of
Evidence
Inclusion criteria &
number of
participants
Intervention of interest Outcomes Number of
treatments
Session
duration
Program
duration
Results
Zinzi et al. [12] 2.d- Pre-test –
post-test
control
group study
40 adults with
early-mid stage
Huntington’s
disease (TFC stages
I-III); mean age
53.6± 14.7 (42.5%
men).
Multi-disciplinary inpatient
rehabilitation program
including respiratory,
occupational, and physical
therapy.
Performance Oriented
Mobility Assessment;
Physical Performance
Test; MMSE; Zung
Scale; and Barthel
Index
18 sessions
repeated 6
times a year
8 hours of
multi-
disciplinary
therapy a
day 5 days a
week and 4
hours on the
week-end
3 weeks
repeated
6 times a
year
Of the 40 participants, only
11 completed the study (6th
admission). Intensive
rehabilitation improved gait
and balance. No changes
seen in cognition and
ADLs. Limited carryover
effects of intervention seen.
ABC scale, Activities-specific Balance Confidence scale; AD, assistive device; ADL, activities of daily living; BBS, Berg Balance Scale; BMI, body mass index; CV, coefficient of variability;
DLPFC, dorsolateral prefrontal cortex; DVD, digital video disc; EQ5D, 5-item EuroQoL; ES, effect size; FEV1, forced expiratory volume in one second; forced vital capacity; GM, grey matter;
HADS, Hospital Anxiety and Depression Scale; HDQoL, Huntington’s Disease Health-Related Quality of Life; HR, heart rate; FSST, four square step test; IPAQ, International Physical Activity
questionnaire; LE, lower extremity; MEP, maximum expiratory pressure; MIP, maximum inspiratory pressure; MMSE, Mini Mental State Examination; MVV, maximal voluntary ventilation;
PCF, peak cough flow; PNF, proprioceptive neuromuscular facilitation; RPE, rating of perceived exertion; OT, occupational therapy; PEF, peak expiratory flow; SF-36, 36-item Short Form Health
Survey; SDMT, symbol digit modalities test; 6MWT, six minute walk test; SNIP, sniff nasal inspiratory pressure; SOT, Sensory Organization Test; 10MWT, ten meter walk test; SWAL QoL,
Swallow Quality of Life questionnaire; TFC, Total Functional Capacity; TUG, Timed Up and Go; UHDRS, Unified Huntington’s disease rating scale; UHDRS-mMS, UHDRS modified motor
score; UHDRS-TMS, Unified Huntington’s Disease Rating Scale-total motor score; VO2 max, peak oxygen uptake; WHO QOL-Bref, World Health Organization Quality of Life-Bref scale.
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on both walking and stairs measured by the Activities
Balance Confidence scale improved in the interven-
tion group but declined in the control group [17].
Kloos et al. [15] reported no significant difference
between the intervention group and the control group
following a video-game balance intervention.
Muscle strength (includes chair stand test). Three
RCTs reported on muscle strength as an outcome
[17, 18, 23]. Strength was assessed with the 15-
repetition chair stand test in one study [18] with
the 30-second chair stand test in another study [23].
The third study did not provide details of strength
assessment [17]. Only one study reported statistically
significant improvement in strength after physical
therapy/exercise [17].
Fitness. Two studies, utilizing data from the same
study population, examined fitness as a primary out-
come [18, 29]. Predicted VO2 max measurements
were calculated before and after a 12-week cycling
and strength training program or usual care [18] or
before and after 12 weeks of cycling and strength
training [29]. Individuals in both intervention groups
demonstrated improvements in actual and predicted
VO2 max [18, 29]. Quinn et al. [18] demonstrated
that the intervention group significantly improved
predicted VO2 max compared to the control group.
Bodyweight. Three studies examined weight or body
mass index (BMI) as a secondary outcome [16–18].
In one study, the intervention group had lower body
weight following a 12-week exercise intervention
than the control group [18]. Thompson et al. [17]
demonstrated that individuals in the exercise inter-
vention increased their total mass while maintaining
their bone mineral density, while individuals in the
control group had an average loss in weight over the
course of the study.
Pulmonary function. Two studies [26, 30] evaluated
pulmonary function as a primary outcome. Although
the intervention type and duration differed (i.e.,
resisted inspirations for 6 weeks [30] vs. progres-
sive resisted inspiratory and expiratory training for
4 months [26]), both studies reported improvements
in inspiratory pressure. Jones et al. [30] reported
improvements in sniff nasal inspiratory pressure and
peak cough flow in both the control group (breathing
exercises without resistance) and the intervention
group with moderate effect sizes (d= 0.36 and 0.37,
respectively), suggesting that regular breathing exer-
cises over a short time frame of 6 weeks could
improve respiratory muscle strength and cough effi-
ciency, regardless of added resistance in persons with
HD. Four months of progressive resisted inspiratory
and expiratory training resulted in greater improve-
ments in maximal inspiratory (d= 0.70 intervention,
d= 0.02 control) and expiratory pressures (d= 0.47
intervention, d= –0.23 control) as well as forced vital
capacity, and peak expiratory flow compared to fixed-
resistance training [26]. This suggests that increasing
the resistance with breathing exercises over time may
produce robust improvements in persons with HD.
Rate of chest infections. Rate of chest infections was
not included in any study as a primary or secondary
outcome.
Ulcer Staging. Ulcer staging was not included in any
study as a primary or secondary outcome.
Cognitive and psychological function
Cognition. Many studies examined cognition as a
secondary outcome; [14, 16–18, 23] only one exam-
ined cognition as a primary outcome [31]. The
most commonly used outcomes were the Symbol
Digit Modalities Test (SDMT), Stroop Test, Hop-
kins Verbal Learning Test-Revised (HVLT-R), and
the UHDRS Cognitive battery, which comprises the
SDMT, Stroop and Verbal Fluency tests.
One study examined cognition and associated grey
matter volume as a primary outcome of exercise
training [31]. This study noted significant improve-
ments in delayed recall and retention (i.e. memory) on
the HVLT-R that were associated with significantly
increased grey matter volume in the dorsolateral
prefrontal cortex [31]. Thompson et al. [17] also
examined HVLT-R performance following a simi-
lar intervention (i.e., multidisciplinary rehabilitation)
and found that both the intervention group and the
control group performed worse following an exercise
training program.
TheUHDRSCognitivebatterywasevaluatedintwo
RCTs [14, 23] and calculated for one [18]. On aver-
age,boththeinterventionandcontrolgroupsimproved
performance, with the control group improving to a
greater degree than the intervention group.
On average, the control and intervention groups
demonstrated maintenance of performance or slight
declines on the SDMT and Stroop components (i.e.,
color, word, interference) [16–18]. Clinically mean-
ingful changes in SDMT and Stroop performance
have not been established for people with HD.
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Depression and Anxiety. Four studies [16–18, 23]
examined depression as a secondary outcome. Only
one study, which utilized a repeated measures design
and did not include a control group, [16] reported
significant reductions in depression scores (i.e.,
improvement) on the Hospital Anxiety and Depres-
sion Scale.
Apathy. Apathy was not included in any study as a
primary or secondary outcome.
Activity limitations
Functional abilities. The Physical Performance Test
was used in three studies [12, 23, 32] to measure
physical activity. Only one study reported significant
improvements following exercise [32].
Physical activity. Two studies examined self-
reported physical activity as a secondary outcome
[14, 18]. There were no significant improvements in
self-reported physical activity in either study.
Number of falls. Number of falls was not reported as
an outcome measure in any of the studies.
Goal attainment. Only one RCT examined goal
attainment, [23] in which participants identified 2–5
goals. The most common goal was related to walking
or stair climbing. Results of this study demonstrated
that by the end of intervention 92% of the goals had
been achieved.
Participation restrictions
Quality of life. Seven studies examined quality of life
as a secondary outcome; outcome tools varied widely,
including the World Health Organization Quality of
Life scale, [15] European Quality of Life-5 Dimen-
sion scale, [18, 23] Huntington’s disease Quality of
Life scale, [23] 36-Item Short Form Health Survey
(SF-36), [13, 14] 12-Item Short Form Health Sur-
vey (SF-12), [16] and Swallowing Quality of Life
Questionnaire, [26] which is specific to quality of
life related to swallowing. Three studies reported sig-
nificant improvements in quality of life following
training. Busse et al. [14] demonstrated significant
improvement on the mental component of the SF-36
following training, while Piira et al. [16], which did
not include a control group, demonstrated significant
improvements on the physical subscale of the SF-12
after training. Finally, Reyes et al. [26] noted mod-
erate effect sizes in both the intervention (d= 0.54)
and control groups (d= 0.38) after respiratory muscle
training.
Qualitative studies
We identified three papers that included quali-
tative analyses for exercise and physical therapy
interventions [33–35]. Zinzi et al. [35] was excluded
following data extraction as the analyses were not
deemed to utilize appropriate qualitative methods.
Frich et al. [33] and Khalil et al. [34] included 26
participants in the early-late stages of HD. Qual-
itative methods utilized were in-depth [33] and
semi-structured [34] interviews, and results were
analyzed using systematic text condensation [33]
and content analysis [34]. Results could be cat-
egorized into two overriding themes: perceived
benefits and barriers, and facilitators to participation
(see Fig. 2).
Perceived benefits. Results suggest that both individ-
uals with HD and their caregivers perceive exercise
as beneficial. Improvements were noted in both phys-
ical (i.e., walking, balance, speech/swallowing, and
motor control, with associated reduction in falls), and
social (i.e., self-confidence, independence, socializa-
tion with family and friends, new friendships, mood,
well-being, and reduced apathy) domains [33] Care-
givers perceived that these benefits lasted for greater
than 1 month.
In addition to the perceived benefit of exer-
cise, individuals with HD and their caregivers also
identified a number of barriers and facilitators to
participation in exercise programs. Barriers included
lack of motivation, cognitive impairment and physi-
cal factors, such as poor balance [33, 34]. Many of
these barriers may be overcome by identified facil-
itators such as identification of a contact person;
[33] indeed, committed caregiver support resulted in
improved outcomes in one study [34]. Further facil-
itators to participation in exercise training included
individualized training, intensive/challenging train-
ing, and group training and cues to improve adherence
(Fig. 2) [33, 34].
DISCUSSION
Our review of eighteen studies with quantitative
outcomes suggests that exercise and physical activity
may be beneficial for individuals with HD in terms
of motor function, gait speed, and balance. Two stud-
ies with qualitative outcomes provide preliminary
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Fig. 2. Summary of results from qualitative studies evaluating exercise and physical therapy interventions in Huntington’s disease (HD).
evidence for patient-reported outcomes, including a
range of physical and social benefits, as well as identi-
fying barriers and facilitators to exercise engagement.
In line with the recently published CONSORT exten-
sion for randomized feasibility and pilot studies, [36]
most studies were appropriately focused on feasibil-
ity, acceptability and preliminary efficacy to provide
support for larger scale trials. Large sample RCTs in
this population remain to be implemented, as do eval-
uation of interventions in people at the prodromal and
advanced stages of HD.
Seven treatment-based classifications (TBCs) have
been previously identified to assist physical therapy
treatment planning for people with HD according to
motor symptoms and physical functioning, [21] and
work is currently underway to establish their valid-
ity [37]. Table 2 lists these classifications along with
a summary of outcome and intervention recommen-
dations. Six studies examined interventions for the
treatment-based classification of Exercise Capacity
and Performance [14, 16–18, 27, 29]. Interventions
utilized in these studies included supervised gym
or clinic-based aerobic (i.e., stationary cycling) and
resistive strengthening exercise programs with or
without additional unsupervised home-based walk-
ing and/or strengthening exercises, [14, 17, 18, 29]
and three-week bouts of multi-disciplinary inpatient
rehabilitation three times a year that included unspec-
ified physical activities in a gym and swimming pool
[16, 27]. In general, the aerobic and resistive exercises
were found to be safe and feasible when performed
3-4 times per week for 30–50 minutes for at least 12
weeks at a moderate intensity [14, 17, 18, 29]. Fol-
lowing the interventions, significant improvements
were reported in aerobic capacity/endurance (VO2
max, 6MWT), [16, 18] motor function (UHDRS-
modified Motor Score), [18] muscle strength, [17]
body composition measures, [16, 17] and mental
health [14, 16, 27]. Taken together these findings pro-
vide good evidence that aerobic and strengthening
exercise programs may be beneficial for improving
exercise capacity and performance in people with
HD in the early to middle stages. Future studies to
determine optimal dosages and the long-term effects
of aerobic and strengthening exercise programs
on functional capacity in individuals with HD are
needed.
Overall there were few studies examining inter-
ventions for the TBC of Planning and Sequencing
of Tasks. Studies in this area were primarily focused
on the impact of exercise on cognition. Two studies
examined the inter-relationship of cognition and exer-
cise [18, 31]. Cruikshank et al. [31] found changes in
the gray matter volume in the caudate and dorsolateral
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Table 2
Treatment-based classifications for exercise and rehabilitation interventions in Huntington’s disease [21]
Classification Description Stage Intervention Recommendations
A. Exercise
capacity and
performance
Absence of motor impairment or specific
limitations in functional activities; potential
for cognitive and/or behavioral issues
Pre-manifest/early Aerobic and resistance exercises
B. Planning and
sequencing of
tasks (including
bradykinesia)
Presence of apraxia or impaired motor planning;
slowness of movement and/or altered force
generation capacity resulting in difficulty and
slowness in performing functional activities
Early-mid Task specific training including strategy
training, sensory stimulation, cueing and
chaining
C. Mobility,
balance and
falls risk
Ambulatory for community and/or household
distances; impairments in balance, strength or
fatigue resulting in mobility limitations and
increased falls risk
Early-mid Balance and gait training; task specific
practice
D. Secondary and
adaptive
changes and
deconditioning
Musculoskeletal and/or respiratory changes
resulting in physical deconditioning, and
subsequent decreased participation in daily
living activities, or social/work environments
Early-mid Patient and caregiver education, maintenance
exercise program, gait and balance training
E. Impaired
postural control
and alignment
in sitting
Altered alignment due to adaptive changes,
involuntary movement, muscle weakness and
incoordination resulting in limitations in
functional activities in sitting
Mid-late Handling and falls risk assessment;
positioning schedule; seating and
wheelchair evaluation
F. Respiratory
dysfunction
Impaired respiratory function and capacity;
limited endurance; impaired airway clearance
resulting in restrictions in functional activities
and risk for infection
Mid-late Functional exercise and ADL training;
positioning; breathing exercises; airway
clearance techniques; relaxation
G. Palliative care Active and passive range of motion limitations
and poor active movement control resulting in
inability to ambulate; dependent for most
activities of daily living; difficulty maintaining
upright sitting position
Late Positioning; range of motion; active
movement exercises
prefrontal cortex after 9 months of 4 hours per
week of exercise and cognitive therapy for an hour
every other week. In addition, there were signifi-
cant improvements in verbal learning and memory
as measured by the HVLT-R. There were no signifi-
cant improvements in cognitive function as measured
by the UHDRS cognitive battery. A shorter duration
aerobic and strengthening program found improve-
ments in motor skills with no significant change in
cognitive function as measured by the UHDRS cog-
nitive battery [18]. It is difficult to draw conclusions
based on these limited and diverse studies. Future
studies may wish to incorporate a measure of verbal
learning and memory such as the HVLT-R to com-
pare to and build on the findings of Cruikshank et al.
[31]. This area of the TBC remains largely unex-
plored; studies to examine impact of planning and
sequencing deficits on function and participation as
well as interventions to best treat these deficits are
needed.
The majority of studies focused on interventions
for the TBC of Mobility, Balance and Fall Risk,
with 13 studies in this area. Interestingly, none of
the measures utilized falls as an outcome measure.
The most common outcome measures were gait speed
(10 studies), Berg Balance Scale (6 studies), Timed
Up and Go (5 studies), UHDRS-TMS and Tinetti
Mobility Test (4 studies) and a variety of measures
of cognition (6 studies). Interventions included aero-
bic exercise with strengthening, aerobic exercise with
functional training, aerobic, strengthening, balance
and functional exercises, video-game based exercise
and assistive device training. A majority of studies
utilized aerobic and strengthening exercise interven-
tions in combination. Exercise interventions were
found to be safe and feasible in this population across
all studies, and there is preliminary evidence to sug-
gest that exercise programs can lead to improvements
in gait and balance. There were a few studies that
demonstrated some improvement in one or more ele-
ments of quality of life [14, 16] while others saw
no improvement [13, 15, 23, 27]. In general sam-
ple sizes were small and control groups generally
continued usual care. Due to the diversity of inter-
ventions and outcome measures it is difficult to draw
conclusions across studies. It is unclear if any benefits
seen were due to any one type of exercise (aerobic,
strengthening or balance) or best achieved through a
combination of any or all of the types of exercise that
have been used to date. Several studies demonstrated
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improvement or maintenance of motor function over
9 months or longer, which is notable in a degenera-
tive condition [16, 17, 27, 31]. Future research should
examine long-term benefits of exercise in HD. This
will be challenging in a degenerative condition where
slowing rate of decline or maintenance of current con-
dition could be an appropriate therapeutic goal. It
may be necessary to establish typical rates of decline
in gait, balance and other domains that are usually
addressed with exercise in order to better establish
that programs can be successful in slowing rate of
decline or maintaining function.
Two small randomized controlled studies exam-
ined interventions for the TBC of respiratory
dysfunction [26, 30]. After home-based interventions
of resistive inspiratory and expiratory respiratory
muscle training, small to moderate improvements
were found in pulmonary function measures, [26, 30]
swallowing, [26] dyspnea, [26] walking endurance,
[26] and cough efficacy [30]. Improvements in maxi-
mum inspiratory and expiratory pressures and forced
vital capacity for the training group greatly exceeded
the control group [26]. These preliminary findings
suggest that resistive respiratory muscle training is
feasible and may be beneficial for individuals with
HD. Larger studies are needed to determine the best
training protocols to achieve optimal pulmonary and
swallowing function across all stages of the disease.
All studies stated that exercise training in individ-
uals with HD was feasible. The majority of studies
focused on individuals in the early-middle stages of
disease, although one study reported feasibility of
training even in the late stage of the disease [18].
A recent case series in late-stage HD also supports
the feasibility and benefits of exercise training [37].
Five studies [12, 18, 23, 24, 32] included follow-
up assessments after the primary intervention period.
These follow-ups ranged in length from six to 24
weeks (average 12.6 weeks) and were either tele-
phone interviews [18, 32] or in-person visits [12,
23, 24]. The results of follow-up visits were vari-
able; studies utilizing telephone interviews reported
that individuals with HD returned to lower levels of
self-reported activity (International Physical Activity
Questionnaire) while maintaining general health rat-
ings (European Quality of Life scale-5 Dimensions)
[18] and that improvements in independence on the
Barthel Index were lost at a 12 week follow-up [32].
Interestingly, Zinzi et al. reported maintenance of
motor function over 2 years as measured by physical
performance test [12]. Maintenance of motor func-
tion in individuals with HD represents an important
clinical outcome of exercise training, as the natural
course of HD is marked by progressive decline.
There are several limitations to this review that
are important to highlight. The lack of standard out-
come measures across studies limited our ability to
conduct a meta-analysis, and this would clearly be
an important next step for future studies. In addi-
tion, future work should utilize hypothesis-driven
outcomes assessment targeted at specific cognitive
or behavioral aspects of HD. This is particularly
important because the effect of exercise on cogni-
tive function is not clear. In addition, the benefit
of exercise and physical activity on other health-
related outcomes such as sleep, bowel function, and
blood pressure should be explored. The lack of con-
trol groups in the multidisciplinary research studies
limited the interpretability of the intervention effi-
cacy compared to natural disease progression and to
tease out the active ingredients of the interventions
when they were so multi-faceted. The heterogene-
ity of disability levels and disease stages across
the studies also affected our ability to make mean-
ingful comparisons of effectiveness across disease
stages. Better incorporation of staging criteria and
clearly defined inclusion criteria is essential in future
studies.
It is important to establish the mode of exercise
that has the best chance of facilitating disease modifi-
cation or attenuating disease progression. All studies
we evaluated had relatively small sample sizes, which
may be largely due to the low prevalence of HD and
the time commitment and effort required for exer-
cise and physical therapy interventions. Importantly,
involvement of caregivers may improve adherence to
exercise programs [33, 34, 38]. Strategies to facilitate
recruitment to exercise studies should be imple-
mented across networks such as Huntington Study
Group (US) and the European Huntington Disease
Network (Europe). Furthermore, incorporating future
interventions as sub-studies of current longitudinal
registry datasets (e.g. Enroll-HD) will be particularly
useful for comparative analysis on disease progres-
sion measures and to minimize subject burden.
In order to facilitate implementation of exer-
cise interventions into clinical practice, studies with
longer follow up duration are needed. Studies of at
least 6 months duration would be able to elucidate the
potential for exercise and physical activity to have a
disease modifying effect in HD. Such longer term
studies would also likely require the utilization of
more reliable measures of exercise adherence, such
as the use of wearable digital devices to track physical
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activity as well as other health-related outcomes (e.g.
sleep and sedentary behaviors).
While the review may highlight the need for high
quality RCTs of exercise interventions, it is important
to consider recent recommendations for interven-
tion studies in rare diseases when planning definitive
evaluations [39–42]. In small sample studies, ran-
dom subject assignment may not always balance out
subject characteristics due to the inherent heterogene-
ity. An alternative is to broaden subject inclusion
criteria at the risk of increasing within-group vari-
ability and in this respect, it may then be useful to
consider alternative approaches such as cross-over
or within-subject repeated measures designs. Multi-
center collaborations, although imposing logistical
and regulatory challenges, are critical to achiev-
ing sufficient study power and alongside this the
use of either less stringent  levels or one-sided
tests particularly when there are clear a-priori direc-
tional hypotheses could also be considered [42]. The
prospective evaluation of well-considered covariate
factors may also improve precision and increase sta-
tistical power. However, additional consensus would
be needed to inform meaningful evaluation of out-
comes in this respect [39]. Adaptive designs, which
allow modification of design elements including re-
estimation of sample size or modification of the
randomization ratio based on accumulating data may
also improve overall efficiency.
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